3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Terminated
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
1
Disease
1
Interventions
TIC10 compound
2
3-Iodobenzylguanidine
2
tucatinib
1
rindopepimut
1
pembrolizumab
1
pegfilgrastim
1
paclitaxel-Angiopep-2 conjugate
1
omburtamab I-131
1
mogamulizumab
1
gallium maltolate
1
fluorodopa F 18
1
efineptakin alfa
1
avapritinib
1
Vorinostat
1
Potassium Iodide
1
OKN 007
1
Ketoconazole
1
Ipilimumab
1
Granulocyte Colony-Stimulating Factor
1
Fenretinide
1
Cancer Vaccines
1
Adjuvants, Immunologic
1
ABT-414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
ABT-414
×
CNS
×
Clear all
NCT03123952
2019-07-15
Expanded Access to ABT-414
AbbVie
No longer available